Brief: Immuneering Reports Second Quarter 2021 Financial Results And Provides Business Updates09/09/2021 13:08
Brief: Immuneering Pricing Of Upsized IPO Of 7.5 Mln Shares Of Class A Common Stock At $15 Per Share30/07/2021 03:53
Last trade - 00:00